Patents, Trade Secrets, and Protection of Innovation in UK Law

Patents, Trade Secrets, and Protection of Innovation in UK Law

Introduction

Innovation is one of the principal drivers of economic development, industrial progress, and commercial competition. New technologies, manufacturing processes, pharmaceutical products, software-related inventions, engineering solutions, and scientific discoveries can create considerable economic value. However, innovation also creates a legal challenge: how can individuals and businesses protect the knowledge, investment, and technical developments that give them a competitive advantage?

Intellectual property law addresses this challenge through several complementary mechanisms. Among the most important are patents and trade secrets. Both can protect valuable technological and commercial knowledge, but they operate according to fundamentally different legal principles.

A patent grants its proprietor a legally enforceable exclusive right over a qualifying invention for a limited period, generally in exchange for publicly disclosing the invention in sufficient detail. A trade secret, by contrast, protects commercially valuable information that remains confidential and derives value from not being generally known. Its protection depends on maintaining secrecy and preventing or remedying unlawful acquisition, use, or disclosure.

These two mechanisms reflect different approaches to the relationship between innovation and public knowledge. Patent law encourages inventors to disclose technical developments so that society can benefit from published knowledge while granting inventors a temporary period of exclusivity. Trade secret law permits businesses to retain valuable information privately, provided that the information satisfies the legal requirements for protection and reasonable steps are taken to preserve its confidentiality.

In the United Kingdom, patent protection is principally governed by the Patents Act 1977, supplemented by relevant regulations, international agreements, and judicial decisions. Trade secret protection is primarily addressed through the Trade Secrets (Enforcement, etc.) Regulations 2018, together with contractual obligations, equitable principles of confidence, and other relevant legal rules.

Although these rights form part of the wider intellectual property framework, their practical importance extends beyond traditional intellectual property registration. They influence employment relationships, research and development agreements, commercial partnerships, technology licensing, investment transactions, industrial competition, and the management of confidential business information.

For England and Wales, the subject is particularly important because patent and trade secret disputes may involve complex questions of ownership, contractual interpretation, technical evidence, confidentiality, and commercial exploitation. The law must protect legitimate innovation without preventing independent research, lawful competition, employee mobility, or the development of competing technologies.

Understanding the distinction between patents and trade secrets is therefore essential to understanding how UK law protects innovation.

1. The Legal Framework for Protecting Innovation in the United Kingdom

The legal protection of innovation is not governed by a single statute. Instead, it operates through a combination of intellectual property legislation, confidentiality rules, contractual obligations, and judicial principles.

The principal statutory sources are the Patents Act 1977 and the Trade Secrets (Enforcement, etc.) Regulations 2018.

1.1 The Patents Act 1977

The Patents Act 1977 is the central statute governing patents in the United Kingdom.

It establishes:

• The legal requirements for patentability.
• The procedures for applying for and obtaining patents.
• The rights granted to patent proprietors.
• The rules governing patent ownership and employee inventions.
• The grounds on which patents may be opposed, amended, revoked, or declared invalid.
• The legal consequences of patent infringement.
• The remedies available to patent proprietors.

The legislation was designed to establish a coherent patent system while aligning UK law with important international developments in intellectual property protection.

The UK patent system is administered principally by the UK Intellectual Property Office (IPO).

The IPO receives and examines patent applications, maintains the patent register, administers relevant opposition and administrative procedures, and provides official guidance to applicants and rights holders.

Patent disputes may ultimately be determined by the courts, particularly the specialist intellectual property jurisdiction of the High Court and the Intellectual Property Enterprise Court.

1.2 The Trade Secrets (Enforcement, etc.) Regulations 2018

Trade secrets are protected through a combination of statutory and non-statutory rules.

The Trade Secrets (Enforcement, etc.) Regulations 2018 implemented the relevant European trade secrets framework into UK law and continue to provide the principal statutory mechanism for civil enforcement of trade secret protection.

The Regulations identify the circumstances in which information qualifies as a trade secret and establish rules governing its unlawful acquisition, use, and disclosure.

They also provide remedies for trade secret holders, including injunctions, damages, and other measures intended to prevent or address unlawful exploitation.

Unlike patents, trade secrets do not require registration or publication. Their protection depends on the nature of the information and the circumstances in which it is maintained and obtained.

1.3 The law of confidence

The law of confidence is an important additional source of protection.

Confidential information may be protected through equitable principles even where it does not satisfy every requirement of statutory trade secret protection.

The traditional principles are associated with Coco v A N Clark (Engineers) Ltd [1969] RPC 41.

The case established three central elements commonly considered in breach of confidence claims:

1. The information must possess the necessary quality of confidence.
2. It must have been communicated in circumstances importing an obligation of confidence.
3. There must be unauthorised use or disclosure to the detriment of the party communicating it.

These principles remain important in disputes involving commercial information, business negotiations, technical developments, and confidential communications.

1.4 International and European influences

The UK patent system operates within an international framework.

Important instruments include:

• The Paris Convention for the Protection of Industrial Property.
• The Patent Cooperation Treaty (PCT).
• The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
• The European Patent Convention (EPC).

The European Patent Convention is particularly significant because it establishes a regional patent application and examination system administered by the European Patent Office.

The United Kingdom remains a contracting state to the EPC following Brexit.

However, an important distinction must be maintained between a European patent application and a European Union intellectual property right. The European Patent Office is not an EU institution, and the UK’s participation in the EPC is independent of EU membership.

The European patent framework therefore continues to provide an important route through which inventors can seek patent protection covering the United Kingdom and other designated contracting states.

2. Patents: Legal Protection of Technological Inventions

A patent is a statutory intellectual property right granted in respect of an invention that satisfies the legal requirements of patentability.

Its central purpose is to encourage technological innovation by granting inventors a temporary period of exclusivity in return for making their inventions publicly available.

The patent system therefore operates through an exchange. The inventor discloses the technical knowledge underlying the invention, while the state grants legally enforceable rights that may prevent others from exploiting the patented invention without permission.

This arrangement has two important consequences.

First, the inventor may commercialise the invention, license it to others, or use the patent as an asset in investment and commercial transactions.

Second, the published patent becomes part of the body of publicly accessible technical knowledge. Other researchers and businesses can study it, develop alternative solutions, and build upon knowledge that is no longer commercially secret.

2.1 What constitutes a patentable invention?

Section 1 of the Patents Act 1977 establishes four principal requirements for patentability.

An invention must:

1. Be new.
2. Involve an inventive step.
3. Be capable of industrial application.
4. Not fall within the statutory exclusions.

These requirements are cumulative. An invention that satisfies three of them but fails the fourth cannot be granted a patent.

The assessment is objective and concerns the technical characteristics of the invention rather than simply its commercial attractiveness or the amount of money invested in its development.

2.2 Novelty

Under section 2 of the Patents Act 1977, an invention is new if it does not form part of the state of the art.

The state of the art includes information made available to the public anywhere in the world before the relevant priority date.

Disclosure may occur through:

• Written publications.
• Scientific and technical articles.
• Earlier patent applications.
• Public demonstrations.
• Commercial use.
• Oral presentations.
• Online publications and technical documentation.

The geographical scope of the novelty assessment is therefore international.

An invention does not become new merely because it has not previously been used in the United Kingdom. If the relevant technical information was already publicly available elsewhere, it may destroy novelty.

For example, an engineer developing a new industrial cooling system may discover that a technical publication from another country describes the same invention in sufficient detail. Even if the system has never been marketed in the United Kingdom, the earlier disclosure may prevent a valid patent from being granted.

The timing of disclosure is consequently critical.

An inventor who publishes technical details, demonstrates a prototype publicly, or presents an invention at an unrestricted conference before filing a patent application may seriously jeopardise the possibility of obtaining protection.

Unlike some other intellectual property systems, UK patent law does not provide a general grace period allowing inventors to disclose their inventions publicly and then apply for a patent within a specified period.

Limited statutory exceptions exist, but they should not be treated as a substitute for filing before disclosure.

2.3 Inventive step

Section 3 of the Patents Act 1977 requires an invention to involve an inventive step.

An invention lacks an inventive step if it would have been obvious to a person skilled in the relevant technical field, having regard to the state of the art.

The assessment is not based on whether the invention appears ingenious to the general public.

Instead, the law adopts the perspective of a hypothetical person possessing the ordinary technical knowledge and skills relevant to the field.

The question is whether that person, considering the existing technical information, would have arrived at the invention without requiring an inventive contribution.

This requirement prevents patents from being granted for developments that merely represent routine technical improvements or predictable applications of existing knowledge.

The leading decision concerning the assessment of inventive step includes Windsurfing International Inc v Tabur Marine (Great Britain) Ltd [1985] RPC 59. The approach developed in that case was subsequently reformulated in Pozzoli SpA v BDMO SA [2007] EWCA Civ 588.

The Pozzoli approach involves identifying the notional person skilled in the art, identifying the relevant common general knowledge, determining the inventive concept of the claim, and assessing whether the differences between the prior art and the claimed invention would have been obvious.

The assessment is technical and fact-sensitive.

An invention does not necessarily lack an inventive step merely because it combines existing components. A particular combination may produce a technical result that would not have been obvious to the skilled person.

2.4 Industrial applicability

Section 4 of the Patents Act 1977 requires an invention to be capable of industrial application.

An invention is capable of industrial application if it can be made or used in any kind of industry, including agriculture.

The concept of industry is interpreted broadly.

It includes manufacturing, engineering, pharmaceuticals, energy production, telecommunications, agriculture, and other fields involving practical application.

An invention does not have to be commercially successful or already manufactured on a large scale.

It must, however, possess a sufficiently credible practical application.

A purely abstract theory without an identifiable industrial application will not normally satisfy this requirement.

For example, a new scientific principle may be intellectually significant, but the principle itself is not necessarily patentable. A practical technical application implementing that principle may qualify if it satisfies the other statutory requirements.

2.5 Subject matter excluded from patent protection

Not every discovery or intellectual development can be patented.

Section 1(2) of the Patents Act 1977 identifies categories that are not treated as inventions for patent purposes to the extent that an application relates to them as such.

These include:

Discoveries, scientific theories, and mathematical methods.

The discovery of a natural phenomenon or mathematical relationship does not automatically qualify for patent protection.

Literary, dramatic, musical, and artistic works.

These are generally protected, where eligible, through copyright rather than patent law.

Schemes, rules, and methods for performing mental acts, playing games, or doing business.

A business method as such is excluded, although an invention involving a qualifying technical contribution may require a different assessment.

Computer programs as such.

Computer programs are excluded from patentability as such. However, computer-implemented inventions may qualify where they involve a technical contribution that satisfies the relevant patentability requirements.

Presentations of information.

The mere presentation of information does not constitute a patentable invention.

The distinction between an excluded subject matter category and a technical invention involving that category is important.

For example, a computer program that merely automates a commercial administrative procedure may face the statutory exclusion. A computer-implemented invention that produces a qualifying technical effect may be assessed differently.

The legal treatment of computer-implemented inventions is an evolving and technically complex area.

There are also specific statutory exclusions concerning certain biological, medical, and other subject matters under sections 1(3) and 4A of the Act.

2.6 Patentable inventions and artificial intelligence

Artificial intelligence has introduced additional questions into patent law.

AI systems may contribute to the development of new technical solutions, assist researchers in identifying compounds, optimise industrial processes, and generate possible engineering designs.

However, the patent system continues to distinguish between the technological contribution made by a system and the legal requirements governing patent entitlement and inventorship.

Under UK law, an inventor must be a natural person.

The Supreme Court confirmed this principle in Thaler v Comptroller-General of Patents, Designs and Trade Marks [2023] UKSC 49.

The case concerned patent applications identifying an artificial intelligence system, DABUS, as the inventor.

The Supreme Court held that an AI machine could not be recognised as an inventor under the Patents Act 1977. The statutory concept of an inventor refers to a natural person.

The decision does not mean that inventions developed with assistance from AI are necessarily unpatentable.

Where a human inventor makes a qualifying inventive contribution using AI as a tool, the application must be assessed under the ordinary statutory requirements.

The distinction is between using artificial intelligence to assist human invention and treating the machine itself as the legal inventor.

2.7 Patent applications and the registration process

Patent protection is obtained through a formal application process.

In the United Kingdom, applications are generally submitted to the IPO.

The process involves several stages.

Preparation of the application.

The applicant must describe the invention sufficiently clearly and completely to enable a person skilled in the relevant technical field to perform it.

The application ordinarily contains:

• A description of the invention.
• One or more patent claims.
• An abstract.
• Drawings where necessary.
• Information identifying the applicant and inventor.

Filing and priority date.

The filing date is important because it establishes the date against which relevant prior art and subsequent applications are assessed.

Where an applicant has previously filed an application for the same invention in another qualifying jurisdiction, priority may be claimed in accordance with the applicable statutory and international rules.

The priority date can therefore differ from the date of the later UK application.

Search and examination.

The IPO conducts the relevant search and examination procedures to determine whether the application satisfies the statutory requirements.

The examiner may identify earlier publications, question the inventive step, or raise objections concerning the clarity and sufficiency of the claims.

Publication.

Patent applications are ordinarily published approximately 18 months after the relevant priority date, subject to the statutory framework.

Publication makes the technical disclosure accessible to the public.

Substantive examination and grant.

The applicant may respond to objections and amend the application within the permitted limits.

If the requirements are satisfied, the patent may be granted.

The process requires careful drafting because the claims determine the scope of the protection sought.

An invention may be technically valuable but receive narrower protection than expected if the claims are inadequately formulated.

2.8 The importance of patent claims

Patent claims define the legal boundaries of the invention for which protection is sought.

The description explains the technical development, while the claims identify the features that the applicant seeks to protect.

The distinction is fundamental.

For example, an engineer may develop a new water filtration device containing several technical improvements. The patent application may describe the entire device, but the claims determine which combinations of technical features fall within the requested monopoly.

Claims that are too narrow may allow competitors to develop close alternatives outside their scope.

Claims that are too broad may encounter objections based on prior art, lack of support, or insufficient disclosure.

The interpretation of patent claims is therefore central to infringement and validity disputes.

2.9 Duration of patent protection

A UK patent generally lasts for a maximum of 20 years from the filing date of the application, provided the required renewal fees are paid and the patent remains in force.

The proprietor must maintain the patent by paying annual renewal fees.

Failure to satisfy the relevant renewal requirements may result in the patent ceasing to have effect, subject to statutory provisions concerning late payment and restoration.

The 20-year term reflects the balance between rewarding innovation and allowing technical knowledge eventually to enter the public domain.

Once the patent expires, the invention is generally free for others to exploit, subject to any separate intellectual property rights that may still apply.

Certain pharmaceutical and plant protection products may qualify for supplementary protection mechanisms under specific legislation. These mechanisms are distinct from ordinary patent renewal and have their own eligibility conditions.

2.10 Patent ownership and transfer

A patent is a form of personal property under section 30 of the Patents Act 1977.

Ownership may arise through entitlement to the invention, assignment, employment-related rules, or succession.

The distinction between an inventor and a patent proprietor is important.

The inventor is the person who devises the invention in the legally relevant sense. The proprietor is the person or entity legally entitled to the patent.

These may be different persons.

For example, an employee may develop a new manufacturing process, while the employer becomes entitled to the patent under section 39 of the Act.

Similarly, an independent inventor may assign patent rights to a company in return for payment or another commercial benefit.

Patents can be:

• Assigned to another person or company.
• Licensed on exclusive or non-exclusive terms.
• Used as assets in commercial transactions.
• Transferred through corporate restructuring.
• Inherited or transferred in accordance with applicable succession rules.

Assignments and other transactions should be properly documented, and relevant changes should be recorded with the IPO where required or commercially appropriate.

2.11 Patent licensing

Licensing enables a patent proprietor to permit another person to exploit an invention without transferring ownership.

A licence may cover manufacturing, importing, selling, using, or otherwise exploiting the patented technology within an agreed scope.

Licensing is particularly important in industries where research and development are expensive and technical innovation requires collaboration between several organisations.

For example, a pharmaceutical research company may own a patent covering a new compound but lack the manufacturing infrastructure necessary for large-scale commercial production.

It may license the invention to a pharmaceutical manufacturer in exchange for royalties or other financial consideration.

Patent licences commonly regulate:

• The territory of exploitation.
• The duration of the licence.
• Permitted technical applications.
• Manufacturing and distribution rights.
• Royalty calculations.
• Reporting and auditing obligations.
• Quality standards.
• Improvements and subsequent inventions.
• Confidentiality.
• Termination and post-termination obligations.

An exclusive licence may provide the licensee with extensive commercial rights, although its precise effect depends on the contractual provisions and statutory framework.

The patent proprietor may retain ownership while receiving royalties and preserving other rights.

2.12 Compulsory licences

Patent protection does not confer an entirely unrestricted commercial monopoly.

The Patents Act 1977 provides mechanisms through which compulsory licences may be granted in specified circumstances.

These provisions recognise that certain uses of patented inventions may raise public-interest concerns, particularly where the exercise of exclusive rights produces legally significant restrictions on competition or access.

Compulsory licensing is subject to statutory conditions and procedures.

It is not a general entitlement for competitors to use patented inventions without permission.

The court or comptroller must consider the relevant legal grounds and circumstances before granting relief.

Compulsory licensing illustrates the principle that patent exclusivity exists within a broader legal framework that takes account of competition, public interests, and the proper functioning of markets.

3. Patent Infringement and Enforcement

Patent protection is meaningful only if the proprietor can enforce the exclusive rights granted by law.

Section 60 of the Patents Act 1977 defines the principal forms of patent infringement.

The statutory provisions distinguish between direct infringement and certain forms of indirect infringement.

3.1 Direct infringement

A person may infringe a patent by undertaking specified commercial or technical activities in the United Kingdom without the proprietor’s consent.

Where the patented invention is a product, infringement may involve:

• Making the patented product.
• Disposing of it commercially.
• Offering it for disposal.
• Using it.
• Importing it.
• Keeping it for disposal or other purposes.

Where the invention concerns a process, infringement may involve using the patented process or offering it for use in circumstances satisfying the statutory requirements.

The provisions also cover certain dealings in products obtained directly through the patented process.

The precise analysis depends on the patent claims and the technical characteristics of the allegedly infringing product or process.

3.2 Indirect infringement

Section 60(2) also recognises certain forms of indirect infringement.

A person may infringe a patent by supplying or offering to supply, in the United Kingdom, another person with means relating to an essential element of the invention for putting the invention into effect.

The statutory conditions include knowledge, or circumstances in which it would be obvious to a reasonable person, that the means are suitable for putting the invention into effect and are intended for that purpose in the United Kingdom.

This provision is important because infringement may involve more than manufacturing or selling the complete patented product.

A supplier who knowingly provides essential components intended to implement a patented invention may fall within the statutory framework.

3.3 Interpretation of patent claims

Patent infringement is assessed by interpreting the claims in accordance with the relevant principles of patent law.

The court examines the technical meaning and scope of the claims, taking account of the patent specification and the appropriate legal approach.

The landmark decision in Actavis UK Ltd v Eli Lilly and Company [2017] UKSC 48 is particularly important.

The Supreme Court addressed the doctrine of equivalents and recognised that infringement analysis is not necessarily restricted to a strictly literal comparison between the patented claims and the defendant’s product.

An invention may be infringed where a product or process differs from the literal wording of the claims but constitutes an equivalent under the applicable legal principles.

The decision demonstrates that patent protection must be assessed in the context of both the wording of the claims and the legally recognised scope of equivalents.

3.4 Patent invalidity as a defence

A patent infringement claim may be challenged on the basis that the patent is invalid.

The defendant may argue that the patent should never have been granted because it fails to satisfy the statutory requirements.

Grounds of invalidity may include:

• Lack of novelty.
• Lack of inventive step.
• Lack of industrial applicability.
• Excluded subject matter.
• Insufficient disclosure.
• Lack of support for the claims.
• Added matter resulting from impermissible amendments.

A patent is not automatically valid merely because it has been granted by the IPO.

Its validity may be challenged through the statutory procedures, including revocation proceedings.

This is particularly important in commercial litigation because a defendant accused of infringement may seek to establish that the asserted patent is legally invalid.

3.5 Patent remedies

Section 61 of the Patents Act 1977 provides for several remedies in infringement proceedings.

These include:

Injunctions. The court may restrain continuing or threatened infringement.

Damages. The proprietor may recover compensation for legally recognised loss.

Account of profits. The court may order the infringer to account for profits attributable to the infringement.

Delivery up or destruction. Infringing products may be subject to orders requiring their surrender or destruction.

Declarations. The court may declare that a patent is valid and has been infringed.

Damages and an account of profits are alternative financial remedies in respect of the same infringement; a proprietor cannot recover both for the same infringement.

The appropriate remedy depends on the circumstances, the evidence, and the claimant’s objectives.

3.6 Patent threats and commercial disputes

Patent disputes frequently arise before formal infringement proceedings begin.

A business may receive a letter alleging that its products infringe a patent, or a patent proprietor may threaten proceedings against a distributor, retailer, or manufacturer.

UK law contains specific provisions concerning unjustified threats of intellectual property infringement proceedings.

Sections 70–70F of the Patents Act 1977 establish a statutory framework for actionable threats.

The purpose is to prevent rights holders from using unjustified threats to disrupt legitimate commercial activity.

The law also recognises the importance of allowing genuine patent owners to protect their rights.

The provisions therefore seek to balance the interests of proprietors and those who may be affected by infringement allegations.

Care is required when communicating patent infringement allegations, particularly where threats are directed at commercial customers or other parties in the supply chain.

4. Trade Secrets: Protecting Confidential Commercial and Technical Information

Not every valuable invention or technological development is suitable for patent protection.

In some circumstances, businesses may prefer to preserve commercially valuable information as a trade secret rather than disclose it through a patent application.

A trade secret is confidential information that possesses commercial value because it is secret and has been protected through reasonable measures intended to maintain its confidentiality.

Trade secrets are particularly important in industries where competitive advantage depends on knowledge that cannot easily be reconstructed by competitors.

Examples include:

• Manufacturing processes and industrial techniques.
• Chemical formulas and product compositions.
• Pharmaceutical research data.
• Software algorithms and technical architectures.
• Production methods and quality-control procedures.
• Commercial strategies and pricing models.
• Supplier and distribution information.
• Customer databases and commercially sensitive business information.
• Research findings and experimental results.
• Specialist technical know-how.

The legal protection of trade secrets differs fundamentally from patent protection.

A patent grants an exclusive right over a qualifying invention following public disclosure. A trade secret protects information because it remains confidential.

Consequently, trade secret protection may continue indefinitely, provided the information retains its legally protected characteristics.

However, the holder does not obtain a monopoly against independent discovery or other forms of lawful acquisition.

4.1 The legal definition of a trade secret

Regulation 2 of the Trade Secrets (Enforcement, etc.) Regulations 2018 establishes three cumulative requirements.

Information qualifies as a trade secret where:

1. It is secret because it is not, as a whole or in its particular configuration and combination of components, generally known or readily accessible to persons within the circles that normally deal with that type of information.
2. It has commercial value because it is secret.
3. The person lawfully controlling the information has taken reasonable steps, in the circumstances, to keep it secret.

These requirements establish the legal boundaries of trade secret protection.

A business cannot simply designate all its internal information as a trade secret and expect the courts to protect it automatically.

The information must possess genuine confidentiality and commercial significance, and the holder must demonstrate appropriate protective measures.

4.2 Secrecy and accessibility

The first requirement concerns whether the information is genuinely secret.

Absolute secrecy is not necessary.

Information may be known to a limited number of employees, contractors, commercial partners, or professional advisers without losing its status as a trade secret.

The decisive question is whether the information is generally known or readily accessible within the relevant professional or commercial sector.

For example, a manufacturing company may possess a specialised production process known only to its research team and a small number of authorised technical partners.

The fact that several individuals know the process does not necessarily destroy its confidentiality.

However, if the same process is described in publicly accessible technical publications or routinely used throughout the industry, it may no longer satisfy the statutory definition.

The law also recognises that a particular combination of information may remain secret even where its individual components are publicly known.

For example, several ingredients may be commonly available, but their precise proportions, processing sequence, and interaction may constitute confidential commercial knowledge.

The combination may have commercial value that does not exist in the individual components considered separately.

This distinction is especially relevant to manufacturing, pharmaceutical development, food production, and industrial engineering.

4.3 Commercial value arising from secrecy

The second requirement is that the information must possess commercial value because it is secret.

The value may arise from several factors.

A trade secret may enable a business to manufacture products more efficiently, reduce production costs, improve quality, enter markets more quickly, or offer services that competitors cannot readily reproduce.

For example, a company may have developed a specialised manufacturing technique that reduces the time required to produce a component while maintaining the same technical specifications.

The commercial advantage may lie not in the finished product itself but in the confidential production method.

Similarly, a technology company may possess a proprietary algorithm that improves the performance of its software.

Its commercial value may arise from the fact that competitors cannot easily reproduce the same performance without access to the underlying information.

The value need not necessarily be reflected in an independently established market price.

The relevant question is whether secrecy provides an actual or potential commercial advantage.

4.4 Reasonable steps to preserve confidentiality

The third requirement is particularly important in practice.

The person lawfully controlling the information must have taken reasonable steps to keep it secret.

The law does not prescribe a single security system suitable for every business.

The adequacy of protective measures depends on the nature, sensitivity, and commercial importance of the information, together with the circumstances in which it is used.

Measures may include:

• Confidentiality agreements with employees and contractors.
• Non-disclosure agreements with business partners.
• Password-protected information systems.
• Restricted access to research and development facilities.
• Encryption of sensitive electronic documents.
• Confidentiality classifications and document markings.
• Internal procedures identifying authorised recipients.
• Staff training concerning confidential information.
• Secure storage of prototypes and technical documentation.
• Monitoring and recording access to sensitive information.

A business holding a highly valuable pharmaceutical formula may reasonably be expected to implement more extensive security measures than a small enterprise protecting ordinary internal business records.

The principle is proportionality.

A company should be able to demonstrate that it treated the information as confidential through actual organisational and technical measures, rather than relying exclusively on a general statement that its information was private.

4.5 Types of information protected as trade secrets

Trade secrets may concern technical, scientific, operational, or commercial information.

Technical information.

This may include manufacturing processes, engineering specifications, experimental results, software architecture, algorithms, and specialised production techniques.

Scientific information.

Research findings, experimental data, laboratory procedures, and unpublished technical discoveries may qualify where they satisfy the statutory conditions.

Commercial information.

Pricing strategies, supplier arrangements, customer information, marketing plans, and distribution methods may also constitute trade secrets.

Practical know-how.

Specialist knowledge accumulated through experience and problem-solving may be protected where it possesses the required confidentiality and commercial value.

The concept of know-how is particularly significant in technology licensing and industrial cooperation.

A business may possess valuable technical knowledge that is not itself patentable but nevertheless provides a substantial commercial advantage.

For example, a company may have developed a highly efficient method of calibrating industrial equipment. The method may involve accumulated experience, precise operational settings, and practical techniques that are difficult to reproduce without access to the company’s confidential knowledge.

Such information may be protected through the law of confidence and, where the statutory requirements are satisfied, trade secret legislation.

4.6 Duration of trade secret protection

Unlike patents, trade secrets do not have a predetermined statutory expiry date.

Protection may continue indefinitely, provided the information remains secret, retains commercial value because of that secrecy, and continues to be subject to reasonable protective measures.

This is one of the principal commercial advantages of trade secret protection.

A business that possesses a valuable formula may preserve its competitive advantage for decades without obtaining a patent, provided the information is not lawfully disclosed or independently discovered.

However, indefinite protection should not be confused with permanent exclusivity.

If the information becomes generally available, it may cease to qualify as a trade secret.

Similarly, if the holder fails to take reasonable steps to preserve confidentiality, statutory protection may no longer be available.

The duration of protection therefore depends on continuing compliance with the legal requirements.

5. Unlawful Acquisition, Use, and Disclosure of Trade Secrets

Trade secret protection would have little practical value without mechanisms to prevent unauthorised acquisition, exploitation, and disclosure.

The Trade Secrets (Enforcement, etc.) Regulations 2018 establish circumstances in which conduct involving trade secrets is unlawful.

Regulation 3 links unlawful acquisition, use, and disclosure to the principles of the law of confidence.

This connection is important because the statutory framework operates alongside established equitable principles rather than replacing them.

5.1 Unlawful acquisition

A trade secret may be acquired unlawfully through conduct that is contrary to honest commercial practices.

Examples include:

• Unauthorised access to confidential computer systems.
• Theft of technical documents.
• Misappropriation of research data.
• Industrial espionage.
• Unauthorised copying of confidential production information.
• Obtaining information through deception.
• Breach of a contractual or other confidentiality obligation.

The acquisition does not have to involve physically removing a document.

Copying digital files, extracting confidential information from an electronic database, or obtaining technical knowledge through unauthorised access may also constitute unlawful acquisition.

The circumstances in which information was obtained are therefore central to the legal analysis.

5.2 Unlawful use

A person may unlawfully use a trade secret even without disclosing it to the public.

For example, a former employee may obtain confidential manufacturing information during employment and subsequently use it to establish a competing business.

If the information satisfies the legal definition of a trade secret and its acquisition or use is unlawful, the former employee’s conduct may give rise to legal liability.

Similarly, a commercial partner who receives confidential technical information for the limited purpose of evaluating a proposed joint venture may not use that information independently to develop a competing product.

The legal position depends on the confidentiality obligations, the circumstances of acquisition, and the relevant statutory provisions.

5.3 Unlawful disclosure

Disclosure occurs when protected information is communicated to another person without lawful authority.

Examples include:

• Sending confidential research data to a competitor.
• Publishing an unpublished industrial formula.
• Disclosing proprietary software information to an unauthorised third party.
• Sharing confidential customer information outside the permitted commercial relationship.
• Providing protected technical documentation to another manufacturer.

Disclosure may constitute unlawful conduct even where the recipient does not immediately exploit the information commercially.

The legal concern is that unauthorised disclosure may destroy the secrecy on which the trade secret’s commercial value depends.

5.4 Acquisition and use through third parties

Trade secret disputes may involve several commercial participants.

A person may receive information from someone who acquired it unlawfully, rather than obtaining it directly from the original holder.

The Regulations recognise circumstances in which subsequent acquisition, use, or disclosure may be unlawful where the recipient knew, or ought to have known under the relevant circumstances, that the information originated from unlawful conduct.

This is particularly relevant to supply chains, technology partnerships, outsourced manufacturing, and commercial acquisitions.

A company cannot necessarily avoid liability simply by arguing that it did not personally steal the information.

The circumstances in which it received and subsequently used the information must be examined.

5.5 Lawful acquisition and independent development

Trade secret protection does not create an absolute monopoly over technical or commercial knowledge.

The law recognises several forms of lawful acquisition.

These include:

Independent discovery or creation.

A competitor may independently develop the same manufacturing process, algorithm, or commercial technique without infringing another person’s trade secret rights.

Reverse engineering.

Where a product has been lawfully acquired and the person examining it is free from a relevant legally binding duty restricting such examination, discovering its underlying technical characteristics through reverse engineering may be lawful.

Observation and testing.

Information obtained through observation, study, disassembly, or testing of a publicly available or lawfully possessed product may be acquired lawfully, subject to applicable legal restrictions.

Employee experience and general skills.

Employees do not ordinarily lose the right to use their general knowledge, skills, and experience merely because they acquired them during employment.

However, the position is different where they use or disclose protected confidential information.

This distinction is particularly important when employees move between competing businesses.

The law protects legitimate commercial confidentiality without granting employers ownership over the general professional abilities of their workforce.

5.6 The public interest and lawful disclosure

Trade secret protection must also be considered in the context of wider public interests.

Confidentiality obligations do not necessarily prevent lawful disclosures required by legislation, regulatory authorities, or judicial proceedings.

The Trade Secrets Regulations recognise exceptions and safeguards concerning legitimate conduct, including disclosures required or permitted by law and certain activities undertaken in the public interest.

This is important where confidential information reveals unlawful conduct, serious wrongdoing, or matters requiring regulatory investigation.

Trade secret protection should not be interpreted as a general mechanism for concealing illegal activities or preventing lawful whistleblowing.

The precise legal protection available to a person making a disclosure depends on the applicable statutory conditions and circumstances.

6. Breach of Confidence: The Equitable Foundation of Trade Secret Protection

The law of confidence has developed through judicial decisions and remains a significant part of the protection of commercially sensitive information.

Its importance extends beyond the statutory definition of trade secrets.

Certain information may possess the necessary quality of confidence and attract equitable protection even if a particular statutory trade secret claim is unavailable.

6.1 The principles in Coco v A N Clark

The leading authority is Coco v A N Clark (Engineers) Ltd [1969] RPC 41.

The claimant had developed a moped design and disclosed technical information to a manufacturer in the context of potential commercial cooperation.

The dispute raised the question of whether information communicated during commercial discussions could be protected against unauthorised use.

Megarry J identified three principal elements of a breach of confidence claim.

First, the information must have the necessary quality of confidence.

Second, it must have been communicated in circumstances importing an obligation of confidence.

Third, there must have been unauthorised use of the information to the detriment of the party communicating it.

These principles remain central to equitable confidentiality claims.

6.2 The quality of confidence

Information already in the public domain will not ordinarily satisfy the necessary quality of confidence.

The law protects information that retains a genuinely confidential character.

However, confidentiality does not always depend on whether every individual element of the information is secret.

A particular compilation, arrangement, or combination of information may possess confidential value even where individual elements are publicly available.

The court examines the information as a whole and considers the relevant commercial or professional context.

6.3 Circumstances importing an obligation of confidence

An obligation of confidence may arise through an express agreement, an employment relationship, a commercial arrangement, or the circumstances in which information is communicated.

A formal written agreement is highly useful but is not always necessary.

For example, a company may disclose a prototype and technical specifications to a potential manufacturing partner for the limited purpose of obtaining a production quotation.

The nature and circumstances of the communication may make it clear that the information is being provided confidentially.

A reasonable recipient should recognise that the information is not being supplied for unrestricted use.

6.4 Unauthorised use and detriment

The third element concerns the use of information without lawful authority.

The information must have been used or disclosed in circumstances inconsistent with the obligation of confidence.

Detriment may arise through commercial loss, loss of competitive advantage, unauthorised exploitation, or other recognised harm.

For example, a company may disclose its confidential manufacturing process to a supplier solely for the purpose of producing components.

If the supplier subsequently uses that information to establish an independent competing production operation, the conduct may constitute a breach of confidence.

The claimant must establish the relevant elements on the evidence.

6.5 Employee confidentiality and Faccenda Chicken v Fowler

Confidential information frequently becomes an issue when employees leave an organisation.

The leading decision is Faccenda Chicken Ltd v Fowler [1987] Ch 117.

The Court of Appeal considered the distinction between information that remains confidential after employment and knowledge that an employee may legitimately use in subsequent employment.

The decision recognised that not every item of information acquired during employment remains protected indefinitely.

General knowledge, skills, and experience ordinarily remain available to the employee.

By contrast, information possessing a sufficiently confidential character may remain protected after the employment relationship ends.

The distinction is particularly important in relation to customer information, pricing arrangements, specialised production processes, and technical business knowledge.

The legal assessment depends on the nature of the information, the circumstances in which it was obtained, the contractual obligations, and the degree of confidentiality.

An employer cannot simply classify an employee’s entire professional experience as confidential.

Equally, an employee cannot assume that commercially sensitive information may be freely taken and used merely because it was learned during ordinary working activities.

7. Ownership and Commercial Management of Innovation

The practical value of patents and trade secrets depends substantially on identifying who owns or lawfully controls the relevant information.

This issue is particularly significant where innovation is developed through employment, independent consultancy, research partnerships, universities, and commercial collaborations.

7.1 Ownership of employee inventions

Section 39 of the Patents Act 1977 establishes the principal rules governing employee inventions.

An invention made by an employee generally belongs to the employer where either of two statutory conditions is satisfied.

The first concerns inventions made in the course of the employee’s normal duties or specifically assigned duties, where an invention might reasonably be expected to result from carrying out those duties.

The second concerns inventions made in the course of duties where the employee has a special obligation to further the interests of the employer’s undertaking because of the nature of the responsibilities involved.

In other circumstances, the invention generally belongs to the employee.

The statutory distinction is important because the mere fact that an invention was developed during employment does not automatically mean that the employer owns it.

For example, an engineer employed to develop industrial machinery may create a new technical mechanism as part of their assigned responsibilities. The invention will generally belong to the employer under section 39.

By contrast, an employee who independently develops an unrelated invention outside the scope of their employment duties may retain ownership.

The factual circumstances and statutory requirements must be examined.

7.2 Compensation for employee inventions

Sections 40 and 41 of the Patents Act 1977 provide a mechanism through which certain employees may obtain compensation for inventions belonging to their employers.

Compensation is not automatically payable whenever an employee creates a patentable invention.

The statutory test requires, among other things, that the invention or patent provides an outstanding benefit to the employer and that it is just for the employee to receive compensation.

The assessment considers the benefit derived by the employer and the circumstances of the particular case.

This mechanism recognises that an employee may make an invention of exceptional commercial importance, even where ownership initially belongs to the employer.

It also demonstrates that patent ownership and the financial recognition of an inventor’s contribution are separate legal questions.

7.3 Ownership of trade secrets

Trade secret protection is not based on a conventional registration certificate or a formal patent-style grant.

The Regulations refer to the person lawfully controlling the information as the trade secret holder.

In practice, this may be an individual, company, research institution, or other organisation that lawfully controls commercially valuable confidential information.

Ownership and control may be influenced by employment agreements, consultancy contracts, research agreements, licences, and commercial arrangements.

For example, a technology company may engage an independent software developer to produce a confidential algorithm.

The contractual agreement should establish who owns the resulting intellectual property, who may access the information, and which parties may use or disclose it.

Without clear provisions, disagreements may arise concerning the developer’s retained rights, the company’s commercial use, and the confidentiality obligations of both parties.

7.4 Universities and research institutions

Universities and research institutions frequently generate inventions through publicly funded research, private investment, academic collaboration, and industrial partnerships.

The ownership of resulting inventions may depend on employment arrangements, institutional policies, funding agreements, and contractual provisions.

A university may own an invention developed by an employee in circumstances where the statutory employee-invention rules apply.

Alternatively, a research collaboration may establish joint ownership or allocate rights between the participating institutions.

Commercialisation may occur through:

• Patent applications.
• Technology transfer agreements.
• Research licences.
• Spin-out companies.
• Joint ventures.
• Industrial partnerships.

The decision to publish research results must be coordinated with any intended patent application.

Premature publication may destroy novelty and jeopardise patent protection.

Research institutions therefore frequently require procedures for reviewing proposed publications and presentations before confidential or potentially patentable material is disclosed.

7.5 Confidentiality agreements and non-disclosure agreements

Non-disclosure agreements (NDAs) are among the principal contractual instruments used to protect trade secrets.

They establish obligations governing the receipt, use, storage, and disclosure of confidential information.

An NDA may be used before:

• Commercial negotiations.
• Investment discussions.
• Technology demonstrations.
• Joint research projects.
• Manufacturing arrangements.
• Software development.
• Licensing negotiations.
• Due diligence exercises.

A well-drafted agreement should identify the confidential information with sufficient clarity and establish the permitted purpose for which it may be used.

It should also address:

• Who may receive the information.
• Whether disclosure to professional advisers is permitted.
• The circumstances in which disclosure is legally required.
• Security and storage requirements.
• Restrictions on copying and reproduction.
• Return or destruction of information.
• The duration of confidentiality obligations.
• Treatment of information already known or independently developed.
• The consequences of unauthorised disclosure.

An NDA is not a substitute for reasonable security measures.

A company that distributes highly sensitive information without access controls cannot necessarily establish adequate protection merely by requiring recipients to sign confidentiality agreements.

Effective trade secret management combines contractual, organisational, and technological safeguards.

8. Enforcement of Patent and Trade Secret Rights in England and Wales

The protection of innovation requires effective enforcement mechanisms. A patent or trade secret may represent a substantial commercial asset, but its value can be seriously diminished if competitors exploit it unlawfully.

The legal system provides several mechanisms for addressing infringement and misappropriation, including interim injunctions, final injunctions, damages, accounts of profits, and orders concerning infringing products or confidential materials.

8.1 The courts and specialist intellectual property jurisdiction

Patent and trade secret disputes in England and Wales may be brought before the appropriate courts, depending on the nature and complexity of the proceedings.

The principal forums include:

The High Court – Intellectual Property List.

The specialist intellectual property jurisdiction of the High Court deals with substantial and technically complex disputes.

These may involve pharmaceutical patents, engineering inventions, biotechnology, industrial processes, and commercially significant confidentiality disputes.

The Intellectual Property Enterprise Court (IPEC).

The IPEC provides specialist procedures intended to make intellectual property litigation more accessible and proportionate.

It is particularly relevant to small and medium-sized businesses, independent inventors, and other parties seeking to enforce intellectual property rights without necessarily undertaking extensive High Court litigation.

The IPEC has different procedural tracks, including a small claims track for qualifying intellectual property disputes. Patent claims are not generally suitable for the small claims track.

The Intellectual Property Office.

The IPO also performs certain administrative and adjudicative functions in patent matters, including relevant opposition, entitlement, and revocation procedures.

However, the IPO does not replace the courts in determining every dispute concerning patent infringement or trade secret misappropriation.

8.2 Interim injunctions in innovation disputes

An interim injunction may be necessary where there is a serious risk that confidential information will be disclosed or that a patented invention will be commercially exploited before a trial can take place.

For example, a company discovering that a former business partner intends to publish its confidential manufacturing process may seek an urgent injunction to prevent disclosure.

Similarly, a patent proprietor may seek an interim injunction where a competitor is preparing to launch a product alleged to infringe a valid patent.

The principles established in American Cyanamid Co v Ethicon Ltd [1975] AC 396 remain important.

The court considers whether there is a serious question to be tried, whether damages would provide an adequate remedy, and where the balance of convenience lies.

The court may also consider the wider circumstances, including the public interest and the consequences of granting or refusing the injunction.

In suitable cases, an applicant may be required to provide a cross-undertaking in damages.

8.3 Remedies for trade secret misappropriation

The Trade Secrets (Enforcement, etc.) Regulations 2018 provide specific remedies where unlawful acquisition, use, or disclosure has been established.

Regulation 14 permits the court to order measures including:

• Cessation of unlawful use or disclosure.
• Prohibition of the production or commercialisation of infringing goods.
• Recall of infringing goods from the market.
• Destruction or withdrawal of infringing goods.
• Depriving infringing goods of their unlawful characteristics.
• Delivery up or destruction of documents, electronic files, and other materials containing trade secrets.

The court must consider proportionality and the circumstances of the particular case.

This is especially important where an order could affect employees, commercial partners, customers, or other third parties.

The objective is to prevent unlawful exploitation without imposing unnecessarily extensive restrictions.

8.4 Damages and compensation

A trade secret holder may seek damages where unlawful conduct causes legally recognised loss.

The assessment may consider:

• Lost commercial opportunities.
• Loss of licensing income.
• Damage to competitive advantage.
• Unauthorised commercial exploitation.
• Financial consequences arising from disclosure.
• The economic consequences of infringing products entering the market.

The Trade Secrets Regulations also provide a framework for assessing damages that takes account of relevant factors, including the negative economic consequences suffered by the trade secret holder and the unfair profits obtained by the infringer.

The court may, in appropriate circumstances, consider a hypothetical royalty or licence fee as a basis for assessing compensation.

This can be particularly useful where the financial consequences of misappropriation are difficult to quantify directly.

8.5 Confidentiality during litigation

A significant difficulty in trade secret litigation is that proceedings themselves may expose the information the claimant is attempting to protect.

A business may need to disclose technical documents, manufacturing processes, or confidential commercial data to establish its case.

The Trade Secrets Regulations contain provisions designed to preserve confidentiality during judicial proceedings.

The court may restrict access to documents or hearings containing trade secrets and make appropriate confidentiality orders.

These measures seek to ensure that parties can present their cases without unnecessarily destroying the commercial secrecy that forms the basis of the dispute.

The court must nevertheless balance confidentiality with the principles of open justice and the parties’ right to a fair hearing.

8.6 Limitation and procedural considerations

Patent and trade secret claims are subject to relevant limitation rules and procedural requirements.

The precise limitation period depends on the nature of the cause of action and the legal basis of the proceedings.

For example, claims for breach of contract, breach of confidence, and statutory trade secret violations may raise different questions concerning accrual, continuing conduct, and the application of limitation legislation.

Parties should therefore identify the precise legal basis of the claim before proceedings are commenced.

Evidence should also be preserved promptly.

Electronic communications, access logs, technical records, research documentation, and employment agreements may become important in establishing the acquisition, use, or disclosure of protected information.

9. Patent Protection Compared with Trade Secret Protection

The choice between patent protection and trade secret protection is one of the most important strategic decisions in innovation management.

Neither mechanism is universally preferable.

The appropriate approach depends on the nature of the invention, the possibility of independent development, the risk of reverse engineering, the commercial life of the technology, and the willingness of the business to disclose technical information.

9.1 Principal legal differences

Feature	Patent	Trade secret
Legal basis	Patents Act 1977	Trade Secrets Regulations 2018 and law of confidence
Registration	Required	Not required
Public disclosure	Required	Information must remain secret
Duration	Generally up to 20 years	Potentially indefinite
Protection against independent development	Yes, within the scope of a valid patent	Generally no
Protection against lawful reverse engineering	Yes, subject to patent rights	Generally no
Ownership	Determined by statutory and contractual rules	Lawful control and relevant contractual arrangements
Commercial exploitation	Assignment and licensing	Confidential licensing and contractual arrangements
Renewal	Annual renewal fees	No registration renewal
Principal risk	Invalidity, expiry, or failure to maintain rights	Loss of secrecy or inadequate protective measures

9.2 When patent protection may be appropriate

Patent protection may be suitable where:

• The invention can be clearly described and claimed.
• Competitors could independently develop or reverse engineer the technology.
• The invention has a sufficiently long commercial life to justify filing and maintenance costs.
• The business wants legally enforceable exclusivity.
• The technology is suitable for licensing or investment.
• Public disclosure is commercially acceptable.

For example, a company developing a new medical device may prefer patent protection because competitors could examine the finished product and reproduce its technical features.

A patent may provide a more effective means of preventing unauthorised commercial exploitation than relying exclusively on confidentiality.

9.3 When trade secret protection may be appropriate

Trade secret protection may be more suitable where:

• The information can realistically remain confidential.
• The technology is difficult to reverse engineer.
• The commercial advantage depends on undisclosed technical knowledge.
• The invention does not satisfy patentability requirements.
• The business wishes to avoid public disclosure.
• The information may remain commercially valuable beyond the 20-year patent term.

A classic example is a confidential industrial formula or specialised production process.

If competitors cannot easily identify or reproduce the process from the finished product, maintaining secrecy may provide a long-term commercial advantage.

However, the business must be prepared to implement effective confidentiality arrangements.

9.4 Combining patents and trade secrets

Patent and trade secret protection are not necessarily mutually exclusive.

A business may patent a technical invention while preserving related operational knowledge as a trade secret.

For example, a manufacturer may obtain a patent for a new industrial machine while keeping confidential the precise production settings, calibration procedures, and quality-control techniques used to manufacture it efficiently.

The patent protects the claimed invention, while trade secret protection may cover additional information that remains genuinely confidential.

The boundaries must be carefully defined.

Information disclosed in the patent specification cannot ordinarily remain a trade secret merely because the patent proprietor wishes to treat it as confidential.

A coherent strategy therefore requires identifying which technical features should be disclosed and which separate elements can legitimately remain secret.

10. Protection of Innovation in Modern Commercial and Technological Environments

The economic importance of patents and trade secrets has increased as innovation has become more collaborative, data-driven, and internationally distributed.

Modern businesses rarely develop all their technology independently. They frequently work with universities, external researchers, software developers, suppliers, manufacturers, investors, and commercial partners.

These relationships create opportunities for innovation but also increase the risk of disputes concerning ownership, confidentiality, and commercial exploitation.

10.1 Innovation in software and digital technologies

Software development frequently involves information that may be protected through several intellectual property mechanisms.

Copyright may protect qualifying computer programs as literary works.

Patents may protect computer-implemented inventions where the statutory requirements are satisfied and the invention is not excluded as a computer program as such.

Trade secrets may protect confidential algorithms, technical architecture, proprietary development processes, and other commercially valuable information.

A software business may therefore rely on several complementary forms of protection.

For example, a company developing an industrial automation platform may have:

• Copyright in its source code.
• A patent application covering a qualifying technical solution.
• Trade secret protection for proprietary algorithms and internal technical documentation.
• Confidentiality agreements governing access by employees and external developers.

The legal analysis must identify each asset separately.

10.2 Artificial intelligence and confidential datasets

Artificial intelligence development frequently involves large datasets, technical models, training procedures, and confidential research.

Some of this information may qualify for trade secret protection.

For example, a company may possess a proprietary dataset or specialised training methodology that gives its AI system a competitive advantage.

However, the company must establish that the information satisfies the legal requirements for trade secret protection.

Simply describing a dataset as proprietary does not automatically make it a trade secret.

The business must demonstrate secrecy, commercial value arising from that secrecy, and reasonable protective measures.

Patent law may also be relevant where AI-related developments produce qualifying technical inventions.

The legal questions concerning inventorship, patentability, and AI-assisted research must be distinguished from the confidentiality issues surrounding training data and internal development processes.

10.3 Biotechnology and pharmaceutical innovation

Biotechnology and pharmaceutical development demonstrate the complementary functions of patents and trade secrets particularly clearly.

A pharmaceutical company may seek patents for a new compound, formulation, manufacturing process, or qualifying therapeutic technology.

At the same time, it may preserve certain experimental techniques, manufacturing know-how, and confidential operational information as trade secrets.

Research data may also have substantial commercial value, although its legal treatment depends on the applicable statutory and contractual framework.

The pharmaceutical industry illustrates why innovation protection cannot be reduced to patent registration alone.

Commercial success often depends on a combination of patent rights, confidential information, regulatory data, research partnerships, and licensing agreements.

10.4 Cybersecurity and protection of confidential information

Digital security is central to modern trade secret management.

The unauthorised acquisition of confidential information may occur through cyberattacks, compromised employee accounts, insecure cloud storage, or the theft of electronic devices.

Businesses should therefore integrate intellectual property protection into their wider information-security systems.

Important measures include:

• Access controls based on professional responsibilities.
• Multi-factor authentication.
• Encryption of confidential files.
• Secure backups.
• Monitoring of access to sensitive information.
• Employee security training.
• Procedures for reporting suspected information breaches.
• Controlled sharing with suppliers and contractors.

These measures help demonstrate that reasonable steps have been taken to preserve confidentiality.

They also reduce the practical risk of losing valuable commercial information.

10.5 International commercial protection

Patent and trade secret protection operate differently across national borders.

A UK patent does not automatically protect an invention throughout the world.

Businesses seeking international protection may use the Patent Cooperation Treaty to pursue patent applications in multiple jurisdictions through an international filing process.

The PCT does not itself grant a worldwide patent. It provides a coordinated application procedure through which applicants may subsequently pursue protection in selected national or regional systems.

European patent applications may also be pursued through the European Patent Office under the European Patent Convention.

Trade secret protection depends on the relevant national laws and contractual arrangements.

International businesses should therefore consider confidentiality provisions, governing law, jurisdiction, and enforcement mechanisms when sharing technical information across borders.

A confidentiality agreement governed by English law may provide an important contractual framework, but the practical enforcement of obligations in another jurisdiction may raise additional questions.

10.6 Innovation, competition, and the public interest

Patent and trade secret law must balance private commercial interests against wider economic and public interests.

Patents grant temporary exclusivity, but they require disclosure and eventually allow the invention to enter the public domain.

Trade secrets preserve confidentiality but do not generally prevent competitors from independently discovering the same information.

These distinctions are important for maintaining competition.

If businesses could obtain permanent exclusive rights over every technical development or commercially useful idea, innovation could become restricted rather than encouraged.

Conversely, if innovators had no effective protection against misappropriation, investment in research and development could become commercially unattractive.

The legal framework therefore seeks to provide incentives for innovation while preserving lawful competition, independent research, and the dissemination of knowledge.

11. Practical Legal Considerations for Businesses and Inventors

The effective protection of innovation requires a structured approach to intellectual property management.

Businesses should not wait until a patent dispute or confidentiality breach occurs before identifying their valuable intangible assets.

A sound strategy should include the following considerations.

1. Identify potentially patentable inventions.

Technical developments should be assessed before public disclosure. Inventors should consider novelty, inventive step, industrial applicability, and the statutory exclusions.

2. Maintain confidentiality before filing.

Where patent protection is being considered, technical details should not be disclosed publicly before an appropriate application strategy has been established.

3. Identify and classify trade secrets.

Businesses should determine which technical and commercial information has genuine confidential value and distinguish it from ordinary internal information.

4. Document ownership.

Employment agreements, consultancy contracts, research agreements, and commercial arrangements should address ownership of inventions and confidential information.

5. Implement effective security measures.

Access to confidential technical and commercial information should be restricted to authorised individuals.

6. Use appropriately drafted confidentiality agreements.

NDAs should define the permitted use of information and establish clear obligations concerning disclosure, storage, return, and destruction.

7. Review commercial partnerships.

Joint development projects and technology licensing agreements should clearly allocate intellectual property ownership and exploitation rights.

8. Establish procedures for employee departures.

Businesses should have appropriate procedures for recovering confidential materials, removing access privileges, and reminding departing employees of continuing confidentiality obligations.

9. Monitor potential infringement and misappropriation.

Businesses should investigate suspected unauthorised use promptly and preserve relevant evidence.

10. Review international protection.

Companies operating internationally should consider the territorial scope of their patent rights and the enforceability of their confidentiality arrangements.

Key Takeaways

1. Patent protection is governed principally by the Patents Act 1977. It establishes the requirements for patentability, ownership, registration, infringement, and enforcement.

2. An invention must satisfy four principal requirements to be patentable. It must be new, involve an inventive step, be capable of industrial application, and not fall within the statutory exclusions.

3. Novelty is assessed internationally. Public disclosure anywhere in the world before the relevant priority date may prevent an invention from qualifying for a patent.

4. Patent protection generally lasts for a maximum of 20 years. The proprietor must satisfy annual renewal requirements.

5. The patent claims determine the scope of protection. The technical description and claims must be carefully prepared to establish the invention’s legal boundaries.

6. Trade secrets are protected through statutory and equitable principles. The principal legislation is the Trade Secrets (Enforcement, etc.) Regulations 2018, operating alongside the law of confidence.

7. Trade secrets must satisfy three cumulative conditions. They must be secret, commercially valuable because of their secrecy, and subject to reasonable protective measures.

8. Trade secret protection may continue indefinitely. However, it depends on maintaining confidentiality and does not prevent independent discovery or other lawful acquisition.

9. The law of confidence remains important. Coco v A N Clark established the traditional principles governing breach of confidence.

10. Employee inventions are subject to statutory ownership rules. Section 39 of the Patents Act 1977 determines when an invention belongs to an employer rather than the employee.

11. Patent and trade secret protection can be combined. Businesses may patent certain technical features while maintaining separate operational knowledge as confidential information.

12. Infringement can result in substantial legal consequences. Remedies include injunctions, damages, accounts of profits, and orders concerning infringing products or confidential materials.

13. International protection requires planning. UK patents are territorial, while trade secret protection depends on applicable national laws and enforceable confidentiality arrangements.

14. Effective innovation management involves legal, contractual, and technological safeguards. Intellectual property protection should be incorporated into ordinary business operations.

Frequently Asked Questions (FAQs)

1. What is a patent under UK law?

A patent is a statutory intellectual property right protecting a qualifying invention.

It grants the proprietor exclusive rights to prevent certain unauthorised commercial activities involving the patented invention.

The principal legislation is the Patents Act 1977.

2. What are the four requirements for obtaining a UK patent?

An invention must:

• Be new.
• Involve an inventive step.
• Be capable of industrial application.
• Not fall within the statutory exclusions.

All four requirements must be satisfied.

3. How long does a UK patent last?

A UK patent generally lasts for up to 20 years from the filing date, provided the necessary renewal fees are paid.

Certain pharmaceutical and plant protection products may qualify for additional protection under separate statutory mechanisms.

4. Can an idea be patented in England and Wales?

An abstract idea cannot ordinarily be patented.

The invention must satisfy the statutory requirements and represent a qualifying technical development.

For example, a general idea for improving transportation is not necessarily patentable, but a new technical mechanism implementing that improvement may qualify.

5. Does a patent protect an invention worldwide?

No.

Patent protection is territorial. A UK patent protects the invention within the United Kingdom, not automatically in every other country.

International protection may be pursued through the Patent Cooperation Treaty, the European Patent Convention, and relevant national patent systems.

6. What is a trade secret?

A trade secret is confidential information that has commercial value because it is secret and has been subject to reasonable measures to preserve its confidentiality.

Examples include formulas, manufacturing methods, technical processes, proprietary algorithms, and commercially valuable business information.

7. How long does trade secret protection last?

Trade secret protection has no fixed statutory expiry date.

It may continue indefinitely as long as the information remains secret, possesses commercial value because of that secrecy, and is protected through reasonable measures.

8. Does a business need to register a trade secret?

No.

Trade secrets are not registered with the UK Intellectual Property Office.

Protection arises from the statutory and equitable framework when the relevant requirements are satisfied.

9. What is the difference between a patent and a trade secret?

A patent requires public disclosure and grants a temporary exclusive right.

A trade secret protects confidential information without registration or public disclosure.

A patent may prevent independent commercial exploitation within its scope, whereas trade secret protection generally does not prevent competitors from independently discovering the same information.

10. Can an employee own an invention developed during employment?

Yes, in certain circumstances.

Under section 39 of the Patents Act 1977, an invention generally belongs to the employer where it is created in the course of qualifying employment duties or duties involving the relevant special obligation.

Other inventions generally belong to the employee.

11. Can an employer claim compensation for an employee’s invention?

An employer may own an employee’s invention under section 39.

However, sections 40 and 41 provide a mechanism for employee compensation where the statutory requirements are satisfied, including where the invention or patent provides an outstanding benefit to the employer and compensation is considered just.

12. Is reverse engineering of a trade secret unlawful?

Not necessarily.

Reverse engineering of a product that has been lawfully acquired may be lawful where the person undertaking it is free from a legally binding duty restricting that activity.

However, contractual restrictions, intellectual property rights, and other applicable laws may affect the position.

13. Can confidential information be protected without an NDA?

Yes.

The law of confidence may impose obligations in circumstances where information is communicated in a context that creates an obligation of confidentiality.

However, written confidentiality agreements provide important evidence of the parties’ intentions and help define the permitted use of information.

14. What happens if a competitor steals a trade secret?

The affected business may pursue legal proceedings seeking remedies such as injunctions, damages, and orders requiring the cessation of unlawful use or disclosure.

The Trade Secrets (Enforcement, etc.) Regulations 2018 provide specific remedies for unlawful acquisition, use, and disclosure.

15. Can a company patent an AI-generated invention?

An AI system cannot itself be recognised as an inventor under the Patents Act 1977.

The Supreme Court confirmed this in Thaler v Comptroller-General of Patents, Designs and Trade Marks [2023] UKSC 49.

However, inventions developed with AI assistance may qualify for patent protection where a human inventor makes the relevant inventive contribution and all statutory requirements are satisfied.

16. What is the role of the UK Intellectual Property Office?

The UK IPO administers the national patent system.

Its responsibilities include receiving applications, conducting searches and examinations, granting patents, maintaining registers, and administering relevant patent procedures.

It also provides official guidance to inventors, businesses, and intellectual property professionals.

17. Can patents and trade secrets protect the same technology?

Yes, provided the rights concern appropriately distinct subject matter.

A business may patent a technical invention while preserving separate confidential manufacturing knowledge, operational procedures, or other undisclosed information as trade secrets.

However, information disclosed in a published patent application cannot ordinarily continue to qualify as secret merely because the proprietor wishes to keep it confidential.

18. Which court hears patent and trade secret disputes in England and Wales?

Complex disputes may be heard in the High Court’s specialist intellectual property jurisdiction.

The Intellectual Property Enterprise Court provides an additional specialist forum for qualifying intellectual property claims, particularly those where proportionate procedures are important.

The appropriate court depends on the nature, complexity, value, and procedural requirements of the dispute.

Conclusion

The protection of patents and trade secrets represents one of the most significant aspects of modern intellectual property law. In an economy increasingly dependent on technology, scientific research, industrial development, and specialised commercial knowledge, the ability to protect innovation is essential to both private enterprise and wider economic progress.

The UK legal framework recognises two fundamentally different but complementary approaches.

Patent law encourages inventors to disclose qualifying technical developments in exchange for temporary exclusive rights. Trade secret law protects valuable confidential information against unlawful acquisition, use, and disclosure, allowing commercial knowledge to remain protected for as long as the statutory requirements continue to be satisfied.

Neither mechanism provides an unlimited monopoly over innovation. Patent rights are restricted by their claims, statutory duration, and requirements of validity. Trade secret protection does not prevent independent development, lawful reverse engineering, or legitimate competition.

The distinction is particularly important for businesses deciding how to commercialise new technologies. Some inventions are best protected through patents because their technical features can readily be reproduced. Others may be more effectively protected through confidentiality arrangements because their commercial value lies in knowledge that can realistically remain undisclosed.

In practice, effective innovation protection requires a combination of legal rights, contractual arrangements, organisational procedures, and technological security. Ownership must be established, employee and contractor relationships carefully regulated, and commercially sensitive information appropriately protected.

Ultimately, patent and trade secret law seek to preserve an essential balance between rewarding innovation and maintaining the conditions for future technological development. By protecting legitimate investment without preventing lawful competition and independent discovery, UK law provides a framework within which scientific progress, commercial enterprise, and industrial creativity can develop.

External Legal Sources and Further Reading

The following primary legislation, official government resources, and judicial decisions provide further information on patents and trade secret protection in the United Kingdom.

Primary legislation

1. Patents Act 1977 – The principal statutory framework governing patentability, applications, ownership, infringement, and enforcement.

2. Trade Secrets (Enforcement, etc.) Regulations 2018 – The statutory framework governing trade secret protection and enforcement.

3. Copyright, Designs and Patents Act 1988 – Relevant to copyright protection of software and other creative works that may form part of technological developments.

Official government and regulatory guidance

4. UK Intellectual Property Office – Patents – Official guidance on patent applications, protection, and ownership.

5. UK IPO – Manual of Patent Practice – Detailed guidance on the interpretation and application of the Patents Act 1977. gov.uk+1

6. UK IPO – Section 1: Patentable Inventions – Statutory requirements and exclusions governing patentability. gov.uk

7. UK IPO – Section 39: Employees’ Inventions – The statutory rules determining ownership of employee inventions. gov.uk

8. UK IPO – Section 40: Compensation of Employees for Certain Inventions – Employee compensation where an invention provides an outstanding benefit to the employer. gov.uk

9. UK Government – Protecting Your Ideas, Products and Information – Practical guidance on protecting commercially valuable information and trade secrets. Business Growth Service

10. UK Government – Knowledge Asset Management: Intellectual Property Management – Guidance on managing intellectual property and confidential commercial knowledge. gov.uk

Important judicial decisions

11. Coco v A N Clark (Engineers) Ltd [1969] RPC 41 – The leading authority on the elements of breach of confidence. Judgment and case materials.

12. Faccenda Chicken Ltd v Fowler [1987] Ch 117 – A leading decision concerning confidential information and employee obligations.

13. Pozzoli SpA v BDMO SA [2007] EWCA Civ 588 – Important authority on the assessment of inventive step.

14. Actavis UK Ltd v Eli Lilly and Company [2017] UKSC 48 – A significant Supreme Court decision concerning patent infringement and equivalents.

15. Thaler v Comptroller-General of Patents, Designs and Trade Marks [2023] UKSC 49 – The Supreme Court’s decision concerning AI systems and legal inventorship.

16. Windsurfing International Inc v Tabur Marine (Great Britain) Ltd [1985] RPC 59 – An important historical authority on inventive step.

This article provides general educational information concerning the law applicable in England and Wales. It does not constitute legal advice. Readers should consult current legislation, official guidance, and relevant judicial decisions when assessing specific legal questions.